Progression of Metastatic Pancreatic Cancer
6 Visninger
• 07/30/23
0
0
Indlejre
administrator
Abonnenter
George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer